Barrio, S
Shanafelt, T D
Ojha, J
Chaffee, K G
Secreto, C
Kortüm, K M
Pathangey, S
Van-Dyke, D L
Slager, S L
Fonseca, R
Kay, N E
Braggio, E
Article History
Received: 7 March 2016
Revised: 24 May 2016
Accepted: 3 June 2016
First Online: 14 June 2016
Competing interests
: RF has received a patent for the prognostication of MM based on genetic categorization of the disease. He has received consulting fees from Celgene, Genzyme, BMS, Bayer, Lilly, Onyx, Binding Site, Novartis, Sanofi, Millennium and AMGEN. He also has sponsored research from Onyx. He is also a member of the Scientific Advisory Board of Applied Biosciences.